미국 · 보도자료 · Ocular Therapeutix, Inc. · 2026-10-01 11:00
10월 주요 과학 및 투자자 컨퍼런스 참가 예정
BEDFORD, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming scientific and investor conferences in October 2026.